Table of Content
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Next Generation Sequencing Market
6. Market Share
6.1 By Product
6.2 By Application
6.3 By Technology
6.4 By End User
6.5 By Countries
7. Product
7.1 Instruments
7.2 Reagents & Consumables
7.3 Services
8. Application
8.1 Diagnostics
8.2 Agriculture and Animal Research
8.3 Drug Discovery
8.4 Personalized Medicine and Genetic Screening
8.5 Others
9. Technology
9.1 Sequencing by Synthesis
9.2 Ion Semiconductor Sequencing
9.3 Single Molecule Read Time Sequencing
9.4 Nanopore Sequencing
9.5 Others
10. End User
10.1 Academic and Clinical Research Centers
10.2 Pharmaceutical and Biotechnology Companies
10.3 Hospitals and Clinics
10.4 Others
11. Countries
11.1 North America
11.1.1 United States
11.1.2 Canada
11.2 Europe
11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherlands
11.2.8 Turkey
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Thailand
11.3.6 Malaysia
11.3.7 Indonesia
11.3.8 Australia
11.3.9 New Zealand
11.4 Latin America
11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina
11.5 Middle East & Africa
11.5.1 Saudi Arabia
11.5.2 United Arab Emirates
11.5.3 South Africa
12. Porter’s Five Forces Analysis
12.1 Threat of New Entry
12.2 The Bargaining Power of Buyer
12.3 Threat of Substitution
12.4 The Bargaining Power of Supplier
12.5 Competitive Rivalry
13. SWOT Analysis
13.1 Strengths
13.2 Weaknesses
13.3 Opportunities
13.4 Threats
14. Key Players Analysis
14.1 Illumina
14.1.1 Overview
14.1.2 Recent Development
14.1.3 Revenue
14.2 Thermo Fisher Scientific
14.2.1 Overview
14.2.2 Recent Development
14.2.3 Revenue
14.3 Pacific Biosciences
14.3.1 Overview
14.3.2 Recent Development
14.3.3 Revenue
14.4 QIAGEN N.V
14.4.1 Overview
14.4.2 Recent Development
14.4.3 Revenue
14.5 Roche
14.5.1 Overview
14.5.2 Recent Development
14.5.3 Revenue
14.6 Bio-Rad Laboratories, Inc.
14.6.1 Overview
14.6.2 Recent Development
14.6.3 Revenue
14.7 Takara Bio Inc
14.7.1 Overview
14.7.2 Recent Development
14.7.3 Revenue
14.8 Hamilton Company
14.8.1 Overview
14.8.2 Recent Development
14.8.3 Revenue
14.9 Geneious
14.9.1 Overview
14.9.2 Recent Development
14.9.3 Revenue
14.10 BioM?rieux SA
14.10.1 Overview
14.10.2 Recent Development
14.10.3 Revenue
List of Figures
0
List of Tables
0